Clinical Trials in Qiqihar, China

5 recruiting

Showing 19 of 9 trials

Recruiting
Phase 3

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

Chronic Obstructive Pulmonary Disease
Sanofi942 enrolled194 locationsNCT07190222
Recruiting
Phase 2Phase 3

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of AZD0780 in Participants With Dyslipidaemia

Dyslipidaemia
AstraZeneca360 enrolled43 locationsNCT06834932
Recruiting
Phase 3

A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE

Ischemic Stroke; Ischemic Attack, Transient
Janssen Research & Development, LLC15,000 enrolled880 locationsNCT05702034
Recruiting
Phase 2

Phase 2 Study of Kylo-11 in ASCVD Patients With Elevated Lp(a)

Lipoprotein Disorder
Kylonova (Xiamen) Biopharma co., LTD.204 enrolled43 locationsNCT07327840
Recruiting
Not Applicable

Hyperkalemia Quality Improvement Program (HK-QIP) Study

Hyperkalemia
AstraZeneca1,000 enrolled49 locationsNCT06884267
Recruiting
Phase 3

Early Antiplatelet Administration After Intravenous Thrombolysis for Acute Ischemic Stroke (TREND-IVT)

Acute Ischemic StrokeCerebral Infarction
Capital Medical University1,184 enrolled71 locationsNCT06548971
Recruiting
Phase 3

TQC2731 Clinical Trial for the Treatment of Severe Asthma With Injection

Asthma
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.660 enrolled74 locationsNCT06829784
Recruiting
Phase 2

Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Systemic Lupus Erythematosus

Systemic Lupus Erythematosus (SLE)
Beijing InnoCare Pharma Tech Co., Ltd.186 enrolled41 locationsNCT05688696
Recruiting

A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China

Liver CancerPancreatic CancerGastric Cancer+8 more
Zhujiang Hospital12,000 enrolled50 locationsNCT05638269